Financhill
Buy
74

ABEV Quote, Financials, Valuation and Earnings

Last price:
$2.95
Seasonality move :
6.95%
Day range:
$2.90 - $2.94
52-week range:
$1.82 - $2.94
Dividend yield:
4.43%
P/E ratio:
16.41x
P/S ratio:
2.92x
P/B ratio:
2.66x
Volume:
28.4M
Avg. volume:
25.5M
1-year change:
59.78%
Market cap:
$45.9B
Revenue:
$16.6B
EPS (TTM):
$0.18
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $11.3B $13.5B $15.4B $16B $16.6B
Revenue Growth (YoY) -14.15% 19.29% 14.32% 3.43% 3.94%
 
Cost of Revenues $5.7B $7B $8.3B $8.4B $8.7B
Gross Profit $5.6B $6.5B $7.1B $7.5B $7.9B
Gross Profit Margin 49.91% 48.21% 46.13% 47.15% 47.74%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.4B $4B $4.6B $4.7B $4.9B
Other Inc / (Exp) -$471M -$452.6M -$444.9M -$592.7M -$264.8M
Operating Expenses $3B $3.5B $4B $4.1B $4.3B
Operating Income $2.7B $3.1B $3.1B $3.4B $3.6B
 
Net Interest Expenses $414.8M $334M $596.1M $578.4M $472.7M
EBT. Incl. Unusual Items $2.6B $2.6B $2.8B $3B $3.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $341.7M $118M -$126.9M $15.1M $860.8M
Net Income to Company $2.3B $2.4B $2.9B $3B $2.8B
 
Minority Interest in Earnings $68.3M $83.7M $83.9M $91.8M $76M
Net Income to Common Excl Extra Items $2.3B $2.4B $2.9B $3B $2.8B
 
Basic EPS (Cont. Ops) $0.14 $0.15 $0.18 $0.18 $0.17
Diluted EPS (Cont. Ops) $0.14 $0.15 $0.18 $0.18 $0.17
Weighted Average Basic Share $15.7B $15.7B $15.7B $15.7B $15.7B
Weighted Average Diluted Share $15.9B $15.9B $15.8B $15.8B $15.8B
 
EBITDA $3.7B $4.1B $4.3B $4.7B $4.9B
EBIT $2.7B $3.1B $3.1B $3.4B $3.6B
 
Revenue (Reported) $11.3B $13.5B $15.4B $16B $16.6B
Operating Income (Reported) $2.7B $3.1B $3.1B $3.4B $3.6B
Operating Income (Adjusted) $2.7B $3.1B $3.1B $3.4B $3.6B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $3.5B $3.9B $4.2B $4B $3.8B
Revenue Growth (YoY) 21.84% 11% 6.03% -4.25% -3.98%
 
Cost of Revenues $1.9B $2.1B $2.2B $2.1B $2B
Gross Profit $1.7B $1.8B $1.9B $1.9B $1.8B
Gross Profit Margin 47.25% 45.29% 46.41% 46.93% 47.92%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1B $1.2B $1.2B $1.2B $1.1B
Other Inc / (Exp) -$81.7M -$89.6M -$94.3M -$56.3M --
Operating Expenses $936.2M $1.1B $1B $1B $937.4M
Operating Income $734.4M $702M $908.8M $857M $896.3M
 
Net Interest Expenses $38.6M $65.6M $56.2M $96.2M $60.6M
EBT. Incl. Unusual Items $600.7M $535M $831.2M $835.4M $957.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$112.9M -$78.4M $9.2M $199M $64.3M
Net Income to Company $713M $591.3M $808.1M $655.1M $894.4M
 
Minority Interest in Earnings $30.6M $20.3M $21.1M $19.1M $21.8M
Net Income to Common Excl Extra Items $709.9M $612.9M $822.3M $643.1M $892.6M
 
Basic EPS (Cont. Ops) $0.04 $0.04 $0.05 $0.04 $0.06
Diluted EPS (Cont. Ops) $0.04 $0.04 $0.05 $0.04 $0.06
Weighted Average Basic Share $15.7B $15.7B $15.7B $15.7B $15.6B
Weighted Average Diluted Share $15.9B $15.9B $15.8B $15.8B $15.7B
 
EBITDA $996.4M $992.4M $1.3B $1.2B $1.2B
EBIT $734.4M $702M $908.8M $857M $896.3M
 
Revenue (Reported) $3.5B $3.9B $4.2B $4B $3.8B
Operating Income (Reported) $734.4M $702M $908.8M $857M $896.3M
Operating Income (Adjusted) $734.4M $702M $908.8M $857M $896.3M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $13B $15B $16.3B $16B $15.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6.6B $8.1B $8.6B $8.4B $8.2B
Gross Profit $6.3B $7B $7.6B $7.6B $7.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.8B $4.5B $4.8B $4.7B $4.6B
Other Inc / (Exp) -$373.1M -$462.2M -$576.9M -$388.4M --
Operating Expenses $3.2B $3.9B $4.3B $4.1B $4B
Operating Income $3.1B $3.1B $3.3B $3.4B $3.6B
 
Net Interest Expenses $344.1M $418.2M $575.3M $732.1M $388.8M
EBT. Incl. Unusual Items $3.4B $2.7B $2.9B $3.4B $3.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $341.9M $88.9M -$169M $562.5M $678.2M
Net Income to Company $3.1B $2.6B $3.1B $2.8B $3B
 
Minority Interest in Earnings $77.9M $86.6M $85.5M $79.2M $78.3M
Net Income to Common Excl Extra Items $3B $2.6B $3B $2.8B $2.9B
 
Basic EPS (Cont. Ops) $0.19 $0.16 $0.19 $0.17 $0.18
Diluted EPS (Cont. Ops) $0.19 $0.16 $0.19 $0.17 $0.18
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $4.1B $4.2B $4.6B $4.7B $4.9B
EBIT $3.1B $3.1B $3.3B $3.4B $3.6B
 
Revenue (Reported) $13B $15B $16.3B $16B $15.8B
Operating Income (Reported) $3.1B $3.1B $3.3B $3.4B $3.6B
Operating Income (Adjusted) $3.1B $3.1B $3.3B $3.4B $3.6B
Period Ending 2022-09-30 2023-09-30 2024-09-30 2025-09-30 2026-09-30
Revenue $11.1B $11.9B $11.9B $11.2B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6.1B $6.4B $6.4B $5.9B --
Gross Profit $5B $5.5B $5.6B $5.3B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.4B $3.5B $3.6B $3.3B --
Other Inc / (Exp) -$249.4M -$375.7M -$155M -$245.6M --
Operating Expenses $2.8B $3.1B $3.1B $2.9B --
Operating Income $2.2B $2.4B $2.4B $2.4B --
 
Net Interest Expenses $198.7M $183.9M $334.4M $250.8M --
EBT. Incl. Unusual Items $1.9B $2.1B $2.4B $2.4B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $25M -$25.2M $522.5M $355.1M --
Net Income to Company $1.9B $2.1B $1.9B $2B --
 
Minority Interest in Earnings $61.6M $63.3M $50.8M $53.5M --
Net Income to Common Excl Extra Items $1.9B $2.1B $1.9B $2B --
 
Basic EPS (Cont. Ops) $0.12 $0.13 $0.12 $0.13 --
Diluted EPS (Cont. Ops) $0.12 $0.13 $0.12 $0.13 --
Weighted Average Basic Share $47.2B $47.2B $47.2B $46.9B --
Weighted Average Diluted Share $47.6B $47.5B $47.5B $47.1B --
 
EBITDA $3.1B $3.4B $3.4B $3.3B --
EBIT $2.2B $2.4B $2.4B $2.4B --
 
Revenue (Reported) $11.1B $11.9B $11.9B $11.2B --
Operating Income (Reported) $2.2B $2.4B $2.4B $2.4B --
Operating Income (Adjusted) $2.2B $2.4B $2.4B $2.4B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $3.6B $3.3B $2.9B $3.4B $4.8B
Short Term Investments $327M $343.5M $86M $57.1M $200.9M
Accounts Receivable, Net $805.6M $832.8M $958.1M $1.1B $976.4M
Inventory $1.5B $2B $2.4B $2B $1.9B
Prepaid Expenses $56.5M $94.1M $94.7M $106.2M $114.3M
Other Current Assets $163.5M $194.3M $196.3M $216.9M $252M
Total Current Assets $6.8B $6.9B $7.2B $7.5B $8.8B
 
Property Plant And Equipment $4.8B $5.2B $5.7B $5.5B $4.9B
Long-Term Investments $348.7M $317.2M $350.3M $318.8M $201.1M
Goodwill $7.7B $7.6B $7.7B $7.8B $7.2B
Other Intangibles $1.5B $1.6B $1.7B $2.1B $2B
Other Long-Term Assets $411.9M $370.2M $360.3M $313.3M $236.6M
Total Assets $24.8B $25.6B $26.7B $27.8B $26.9B
 
Accounts Payable $3.5B $4.3B $4.5B $4.4B $3.9B
Accrued Expenses $178M $437.7M $441.7M $438.6M $449.8M
Current Portion Of Long-Term Debt $448.7M $34.8M $37.6M $31.2M $26.5M
Current Portion Of Capital Lease Obligations $78.1M $117.2M $148.2M $236.3M $180M
Other Current Liabilities $418.9M $501.9M $802.3M $1B $581M
Total Current Liabilities $6.4B $7B $7.7B $8.4B $8B
 
Long-Term Debt $395.3M $404.6M $528.1M $453.5M $352.3M
Capital Leases -- -- -- -- --
Total Liabilities $10.4B $10.5B $10.9B $11.3B $10.7B
 
Common Stock $11.1B $10.4B $11B $12B $9.4B
Other Common Equity Adj -- -- -- -- $6.5B
Common Equity $14.2B $14.8B $15.5B $16.3B $16B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $257.1M $246.8M $259.9M $241.8M $151.9M
Total Equity $14.5B $15.1B $15.8B $16.5B $16.1B
 
Total Liabilities and Equity $24.8B $25.6B $26.7B $27.8B $26.9B
Cash and Short Terms $3.6B $3.3B $2.9B $3.4B $4.8B
Total Debt $473.5M $521.8M $676.5M $689.6M $532.4M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $3.7B $3.5B $3.5B $3.8B $3.7B
Short Term Investments $377.4M $249.5M $45.1M $212.4M --
Accounts Receivable, Net $808.2M $962.9M $1.1B $1.1B $1.1B
Inventory $1.7B $2.3B $2.2B $2B $2B
Prepaid Expenses $90.9M $104.9M $115.5M $125.4M $135.7M
Other Current Assets $216.7M $239M $206.1M $284.7M --
Total Current Assets $7B $7.7B $7.5B $7.8B $7.9B
 
Property Plant And Equipment $5B $5.5B $5.8B $5.3B $5B
Long-Term Investments $318.7M $343.8M $329.7M $236.6M $83.6M
Goodwill $7.7B $7.7B $7.9B $7.7B --
Other Intangibles $1.5B $1.7B $1.9B $2.1B --
Other Long-Term Assets $374.6M $364.2M $323.2M $248.9M --
Total Assets $25.7B $26.9B $28.1B $27.6B $27B
 
Accounts Payable $3.4B $3.8B $3.4B $3.5B $3.6B
Accrued Expenses $406.1M $412.2M $448.3M $465.7M --
Current Portion Of Long-Term Debt $37.9M $17.9M $245.4M $29M --
Current Portion Of Capital Lease Obligations $105.9M $123.1M -- $193.8M --
Other Current Liabilities $463.8M $697.3M $944.1M $552M --
Total Current Liabilities $5.7B $6.5B $6.8B $6.6B $6.9B
 
Long-Term Debt $392.5M $410.2M $495.9M $398.3M $346.5M
Capital Leases -- -- -- -- --
Total Liabilities $9.5B $9.9B $9.8B $9.4B $9.6B
 
Common Stock $10.6B $10.7B $11.6B $10.7B $10.9B
Other Common Equity Adj -- -- $3.1B -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $255.8M $253.9M $261M $136.6M $131.6M
Total Equity $16.2B $16.9B $18.3B $18.2B $17.4B
 
Total Liabilities and Equity $25.7B $26.9B $28.1B $27.6B $27B
Cash and Short Terms $3.7B $3.5B $3.5B $3.8B $3.7B
Total Debt $497.8M $533.1M $495.9M $591.8M $512.2M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $2.3B $2.4B $2.9B $3B $2.8B
Depreciation & Amoritzation $1B $1B $1.2B $1.3B $1.3B
Stock-Based Compensation $40.5M $71.8M $60.8M $66.4M $74.4M
Change in Accounts Receivable -$164.6M $63.3M -$62.4M -$275.1M $40.9M
Change in Inventories -$252.7M -$648.5M -$597.9M $260.4M -$315.8M
Cash From Operations $3.7B $4.2B $4B $4.9B $4.8B
 
Capital Expenditures $909.8M $1.4B $1.3B $1.2B $882.2M
Cash Acquisitions $83.7M $24.8M $585K $9.3M $316.6M
Cash From Investing -$1.3B -$1.4B -$969M -$1.2B -$1.3B
 
Dividends Paid (Ex Special Dividend) $1.3B $2.1B $2.4B $2.4B $752.4M
Special Dividend Paid
Long-Term Debt Issued $738.2M $58.5M $53.3M $10M $91.2M
Long-Term Debt Repaid -$497.9M -$578.9M -$210.4M -$282M -$360.7M
Repurchase of Common Stock $1.4M $8.2M $10.5M $23.8M $87M
Other Financing Activities -$582.1M -$388M -$631.3M -$547.2M -$820M
Cash From Financing -$1.7B -$3B -$3.2B -$3.2B -$1.6B
 
Beginning Cash (CF) $3.3B $3B $2.8B $3.3B $4.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1B -$91.4M -$337.9M $241.6M $2.3B
Ending Cash (CF) $4.6B $3B $2.3B $3.2B $7.4B
 
Levered Free Cash Flow $2.7B $2.8B $2.7B $3.7B $4B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $666.9M $993.5M $921.8M $919.6M --
Depreciation & Amoritzation $259.5M $320.1M $310.6M $370.3M --
Stock-Based Compensation $13.9M $18.8M $12.8M $20.6M --
Change in Accounts Receivable $206.3M $98.6M -$159.5M $93M --
Change in Inventories -$277.1M -$167M $94.7M -$77.6M --
Cash From Operations $2.2B $2.3B $2.8B $2.6B --
 
Capital Expenditures $544.2M $398.3M $460.4M $277.1M --
Cash Acquisitions $3.2M $13.6K $71.9K -$7.3M --
Cash From Investing -$481.9M -$215.8M -$456.9M -$259.3M --
 
Dividends Paid (Ex Special Dividend) $1.8B $2.3B $2.3B $733.8M --
Special Dividend Paid -- -- -- -- $49K
Long-Term Debt Issued $7.8M $14.5M $1.9M $8.2M --
Long-Term Debt Repaid -$50.7M -$62.8M -$75.7M -$81M --
Repurchase of Common Stock $120.8K -$399.8K $8.1M $17.7M --
Other Financing Activities -$388M -$102.4M $26M -$196.5M --
Cash From Financing -$1.9B -$2.5B -$2.4B -$987.3M --
 
Beginning Cash (CF) $3B $2.8B $3.3B $4.6B --
Foreign Exchange Rate Adjustment $42.5M -$89M -$212.1M $307.4M --
Additions / Reductions -$214.6M -$468.3M -$267.3M $1.7B --
Ending Cash (CF) $2.8B $2.3B $2.8B $6.6B --
 
Levered Free Cash Flow $1.6B $1.9B $2.3B $2.3B --
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $3.1B $2.6B $3.1B $2.8B $3B
Depreciation & Amoritzation $979.1M $1.1B $1.3B $1.3B $1.3B
Stock-Based Compensation $64.7M $55.9M $72.4M $67.9M $75M
Change in Accounts Receivable -$736.7M $45.3M -$17M -$210.3M $232.6M
Change in Inventories -$472.5M -$708.1M -$1.2M -$149.2M -$84M
Cash From Operations $3.6B $3.9B $4.4B $5.1B $4.6B
 
Capital Expenditures $1.1B $1.4B $1.1B $1.1B $803.7M
Cash Acquisitions $23.6M $3.8M $9.3M $329M -$7.3M
Cash From Investing -$1.2B -$1.2B -$913.3M -$1.6B -$777.9M
 
Dividends Paid (Ex Special Dividend) -- $1.8B $2.4B $2.4B $2.7B
Special Dividend Paid
Long-Term Debt Issued $123.3M $46.7M $22.6M $84.8M --
Long-Term Debt Repaid -$930.6M -$198.3M -$269M -$355.5M --
Repurchase of Common Stock $8.3M $11M $15.3M $78.9M $344.1M
Other Financing Activities -$228.9M -- -$675.5M -$597.5M --
Cash From Financing -$2.9B -$2.6B -$3.3B -$3.1B -$3.8B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$693.2M -$84.2M $40.6M $447.9M -$170.4M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2.5B $2.4B $3.3B $4.1B $3.8B
Period Ending 2022-12-31 2023-12-31 2024-12-31 2025-12-31 2026-12-31
Net Income to Stockholders $2.9B $3B $2.8B $2B --
Depreciation & Amoritzation $1.2B $1.3B $1.3B $892.1M --
Stock-Based Compensation $60.8M $66.4M $75.7M $54.5M --
Change in Accounts Receivable -$62.4M -$275.1M $42.2M $139.5M --
Change in Inventories -$597.9M $260.4M -$321.5M -$6.4M --
Cash From Operations $4B $4.9B $4.9B $2B --
 
Capital Expenditures $1.3B $1.2B $897.2M $526.6M --
Cash Acquisitions $585K $9.3M $321.7M $4.1K --
Cash From Investing -$969M -$1.2B -$1.4B -$518.7M --
 
Dividends Paid (Ex Special Dividend) $2.4B $2.4B $769.8M $1.9B --
Special Dividend Paid -- -- -- $72K --
Long-Term Debt Issued $53.3M $10M $91.2M $9M --
Long-Term Debt Repaid -$210.4M -$282M -$360.7M -$121.1M --
Repurchase of Common Stock $10.5M $23.8M $88.5M $326.4M --
Other Financing Activities -$631.3M -$547.2M -$820M -$287.6M --
Cash From Financing -$3.2B -$3.2B -$1.6B -$2.9B --
 
Beginning Cash (CF) $11.5B $11.7B $13.4B $9.8B --
Foreign Exchange Rate Adjustment -$202.4M -$325M $426.9M -$451M --
Additions / Reductions -$337.9M $241.6M $2.4B -$1.8B --
Ending Cash (CF) $11B $11.6B $16.2B $7.5B --
 
Levered Free Cash Flow $2.7B $3.7B $4B $1.5B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Alerts

Sell
40
BILL alert for Feb 9

Bill Holdings, Inc. [BILL] is up 3.7% over the past day.

Buy
75
PRLB alert for Feb 9

Proto Labs, Inc. [PRLB] is down 2.16% over the past day.

Sell
30
MSTR alert for Feb 9

Strategy, Inc. [MSTR] is up 2.59% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock